Premium
BRENTUXIMAB VEDOTIN POPULATION PHARMACOKINETIC (POPPK) MODELLING IN ADULT AND PAEDIATRIC PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) HEMATOLOGIC MALIGNANCIES
Author(s) -
Suri A.,
Mould D.R.,
Song G.,
Kinley J.,
Venkatakrishnan K.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.209_2631
Subject(s) - medicine , brentuximab vedotin , dosing , body surface area , pharmacokinetics , nonmem , refractory (planetary science) , population , oncology , nuclear medicine , hodgkin lymphoma , lymphoma , physics , environmental health , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom